Surgical Treatment of Juvenile Idiopathic Arthritis in the Era of Novel Drug Therapies.

Abstract

Juvenile idiopathic arthritis is the most common chronic rheumatic disease encountered in children under the age of sixteen and causes significant impairments in daily life. Over the last two decades, the introduction of new drug treatments (including disease-modifying antirheumatic drugs and biologics) has changed the course of this disease, thus reducing the indication for surgery. However, some patients fail to respond to drug therapy and thus require personalized surgical management, e.g., the local reduction of joint effusion or a synovial pannus (via intra-articular corticosteroid injections, synovectomy, or soft tissue release), and management of the sequelae of arthritis (such as growth disorders and joint degeneration). Here, we provide an overview of the surgical indications and outcomes of the following interventions: intra-articular corticosteroid injections, synovectomy, soft tissue release, surgery for growth disorders, and arthroplasty.

• Authors: Céline Klein, Vincent Barbier, Christophe Glorion, Richard Gouron
• Journal: Journal of clinical medicine (J Clin Med) Vol. 12 Issue 10 (May 11 2023) ISSN: 2077-0383 [Print] Switzerland
• PMID: 37240508 (Publication Type: Journal Article)